Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

May 2011 - FRMC

Feature
The Minnesota Community Measurement
05/23/2011

Mary Beth Nierengarten

Mary Beth Nierengarten
A community healthcare initiative in Minnesota is showing that strong collaboration and sharing of information among all key stakeholders can improve outcomes.
A community healthcare initiative in Minnesota is showing that strong collaboration and sharing of information among all key stakeholders can improve outcomes.
A community healthcare...
05/23/2011
First Report Managed Care
Feature
Quality Initiatives in Managing Multiple Sclerosis
05/23/2011

Tim Casey

Tim Casey
Minneapolis—The US Food and Drug Administration has approved several drugs in recent years to treat multiple sclerosis (MS), including fingolimod, the first oral MS therapy. There are also 5 drugs in phase 3 trials intended to treat MS.
Minneapolis—The US Food and Drug Administration has approved several drugs in recent years to treat multiple sclerosis (MS), including fingolimod, the first oral MS therapy. There are also 5 drugs in phase 3 trials intended to treat MS.
Minneapolis—The US Food and Drug...
05/23/2011
First Report Managed Care
Feature
Medication Adherence among Patients with Diabetes in a Managed Care Setting
05/23/2011

Tori Socha

Tori Socha
Minneapolis—It is estimated that only about 50% of patients in the United States take their medications as prescribed. Poor adherence to medication regimens has been shown to have an impact on healthcare costs; approximately $150 billion in...
Minneapolis—It is estimated that only about 50% of patients in the United States take their medications as prescribed. Poor adherence to medication regimens has been shown to have an impact on healthcare costs; approximately $150 billion in...
Minneapolis—It is estimated that...
05/23/2011
First Report Managed Care
Feature
REMS Programs: Trends and Opportunities for Pharmacists
05/23/2011

Tori Socha

Tori Socha
Minneapolis—The drug safety initiatives known as risk evaluation and mitigation strategies (REMS) have evolved over the past 30 years. From 1970 to 2005, drug safety measures largely focused on premarketing and risk assessment. From 2005 to...
Minneapolis—The drug safety initiatives known as risk evaluation and mitigation strategies (REMS) have evolved over the past 30 years. From 1970 to 2005, drug safety measures largely focused on premarketing and risk assessment. From 2005 to...
Minneapolis—The drug safety...
05/23/2011
First Report Managed Care
Feature
Low Adherence Rates to Atypical Antipsychotic Therapy in Patients with Schizophrenia
05/23/2011

Christin Melton

Christin Melton
Minneapolis—A retrospective database study of insurance claims for 63,000 adults with schizophrenia who were prescribed certain oral atypical antipsychotic (AA) medications found that less than one-third (approximately 29.4%) remained...
Minneapolis—A retrospective database study of insurance claims for 63,000 adults with schizophrenia who were prescribed certain oral atypical antipsychotic (AA) medications found that less than one-third (approximately 29.4%) remained...
Minneapolis—A retrospective...
05/23/2011
First Report Managed Care
Feature
Risk-Sharing, Outcomes-Based Contracting Can Increase Accountability in Healthcare
05/23/2011

Jill Sederstrom

Jill Sederstrom
Minneapolis—As the healthcare industry continues to evolve, risk-sharing programs and outcomes-based contracting are placing an increased emphasis on accountability. These concepts were discussed during a contemporary issues session at the...
Minneapolis—As the healthcare industry continues to evolve, risk-sharing programs and outcomes-based contracting are placing an increased emphasis on accountability. These concepts were discussed during a contemporary issues session at the...
Minneapolis—As the healthcare...
05/23/2011
First Report Managed Care
Feature
Quantifying the Cost of Warfarin-Related Bleeding Events in Patients with Atrial Fibrillation
05/23/2011

Christin Melton

Christin Melton
Warfarin prophylaxis reduces the rates of primary and secondary stroke in patients with atrial fibrillation (AF), but at a cost.
Warfarin prophylaxis reduces the rates of primary and secondary stroke in patients with atrial fibrillation (AF), but at a cost.
Warfarin prophylaxis reduces the...
05/23/2011
First Report Managed Care
Feature
Management Strategies for Hematologic Malignancies
05/23/2011

Tim Casey

Tim Casey
Minneapolis—With the introduction of novel agents, healthcare professionals and managed care organizations are determining how to evaluate the new therapies and incorporate them into effective benefit designs. The agents are becoming more...
Minneapolis—With the introduction of novel agents, healthcare professionals and managed care organizations are determining how to evaluate the new therapies and incorporate them into effective benefit designs. The agents are becoming more...
Minneapolis—With the...
05/23/2011
First Report Managed Care
Feature
Cost-Effectiveness and Efficacy of Natalizumab versus Fingolimod
05/23/2011

Tori Socha

Tori Socha
Minneapolis—Multiple sclerosis (MS) is a chronic, disabling disease of the central nervous system. It affects approximately 400,000 patients in the United States. The most commonly diagnosed category of MS is relapsing-remitting multiple...
Minneapolis—Multiple sclerosis (MS) is a chronic, disabling disease of the central nervous system. It affects approximately 400,000 patients in the United States. The most commonly diagnosed category of MS is relapsing-remitting multiple...
Minneapolis—Multiple sclerosis...
05/23/2011
First Report Managed Care

Department

Conference Insider
Costs of Switching TNF Agents versus Dose Escalation
05/23/2011

Tori Socha

Tori Socha
Minneapolis—As patients and physicians seek improved disease control, switching among anti–tumor necrosis factor (TNF) agents has become common practice, according to the authors of a recent study. Study results were presented at an AMCP...
Minneapolis—As patients and physicians seek improved disease control, switching among anti–tumor necrosis factor (TNF) agents has become common practice, according to the authors of a recent study. Study results were presented at an AMCP...
Minneapolis—As patients and...
05/23/2011
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 2

Current Issue

June 2024
Volume 21
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Cigna Reports Cost Savings Associated With Fusing Medical, Drug, and Behavioral Benefits
01/07/2020
"Our integrated approach maximizes every opportunity to deliver a health care experience that is affordable, predictable and simple," said Matt Totterdale, senior vice president, Cigna Pharmacy.
"Our integrated approach maximizes every opportunity to deliver a health care experience that is affordable, predictable and simple," said Matt Totterdale, senior vice president, Cigna Pharmacy.
"Our integrated approach...
01/07/2020
First Report Managed Care
News
Foes of new health system more likely to vote Nov. 2
09/27/2010
09/27/2010
First Report Managed Care
Conference Insider
New Shingles Vaccine Cost-Effective, Cost-Saving Compared With Zostavax
05/31/2018
Research presented at the AMCP 2018 Annual Meeting found that Shingrix (non-live adjuvanted subunit vaccine; GlaxosmithKline) is cost-effective when compared with no vaccination and cost-saving compared with an older shingles vaccine.
Research presented at the AMCP 2018 Annual Meeting found that Shingrix (non-live adjuvanted subunit vaccine; GlaxosmithKline) is cost-effective when compared with no vaccination and cost-saving compared with an older shingles vaccine.
Research presented at the AMCP...
05/31/2018
First Report Managed Care
News
Jentadueto Approved for Type 2 Diabetes
01/31/2012
The US Food and Drug Administration (FDA) announced on Monday that it had approved Jentadueto (linagliptin/metformin hydrochloride), an oral combination therapy to treat patients with type 2 diabetes. The drug is co-marketed by Boehringer...
The US Food and Drug Administration (FDA) announced on Monday that it had approved Jentadueto (linagliptin/metformin hydrochloride), an oral combination therapy to treat patients with type 2 diabetes. The drug is co-marketed by Boehringer...
The US Food and Drug...
01/31/2012
First Report Managed Care
News
Value-Based Contracting Showing Greater Value for Care Provided, Innovative Opportunities
07/13/2015
San Diego—Value-based contracting is demonstrating greater value for care provided, while innovative contracting opportunities are expected to increase in the future, according to a session at the AMCP meeting that included both payer and...
San Diego—Value-based contracting is demonstrating greater value for care provided, while innovative contracting opportunities are expected to increase in the future, according to a session at the AMCP meeting that included both payer and...
San Diego—Value-based...
07/13/2015
First Report Managed Care

Video Insights

Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

May 2011 Volume 8 Issue 5

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement